Evidence map›Paper›PMID 30463988›Full record

ArticleJournal of lipid research2019

Lysophospholipid G protein-coupled receptor binding parameters as determined by backscattering interferometry.

Hirotaka Mizuno, Yasuyuki Kihara, Amanda Kussrow, Allison Chen, Manisha Ray, Richard Rivera, Darryl J Bornhop, Jerold Chun

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. FTY720 requires vitamin BCell reports · 2023
    Article
  4. Review
  5. Article
  6. Ponesimod inhibits astrocyte-mediated neuroinflammation and protects against cingulum demyelination via S1PFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Hirotaka MizunoSanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037.ORCID 0000-0001-7462-3006
Yasuyuki KiharaSanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037.
Amanda KussrowDepartment of Chemistry Vanderbilt University, Nashville, TN 37235.
Allison ChenSanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037.
Manisha RaySanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037.
Richard RiveraSanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037.
Darryl J BornhopDepartment of Chemistry Vanderbilt University, Nashville, TN 37235.
Jerold ChunSanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037 jchun@sbpdiscovery.org.ORCID 0000-0003-3964-0921
Sanford Burnham Prebys Medical Discovery Institute · USVanderbilt University · US

Funding

Prenatal blood-borne lipids in post-hemorrhagic hydrocephalusR01NS084398 · NINDS · SCRIPPS RESEARCH INSTITUTE, THE · PI CHUN, JEROLD · 2014 to 2017
$2.6M
S1P signaling machinery in neuroimmune interactionsR01NS103940 · NINDS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI KIHARA, YASUYUKI · 2018 to 2022
$2.1M
NINDS NIH HHS R01 NS084398NINDS NIH HHS R01 NS103940
6 · The paper itself

Abstract

Lysophosphatidic acid (LPA) activates cognate G protein-coupled receptors (GPCRs) to initiate biological signaling cascades. Lysophospholipid (LP) receptor binding properties remain incompletely assessed because of difficulties with ligand lipophilicity and lipid "stickiness." These inherent attributes produce high levels of nonspecific binding within cell-membrane preparations used to assess GPCRs, as has been shown in classical binding assays using radiolabeled ligands, making accurate measurements of lipid binding kinetics difficult to achieve. Backscattering interferometry (BSI) is an optical technology that measures molecular binding interactions by reporting changes in the refractive index of a solution after binding events. Here, we report the use of BSI to assess LPA

Indexed as

LightBinding, CompetitiveCell LineInterferometryLigandsLysophospholipidsProtein BindingReceptors, G-Protein-CoupledScattering, RadiationSubstrate SpecificityLigandslysophosphatidic acidLysophospholipidsReceptors, G-Protein-Coupledbinding assayendocannabinoidlipidmolecular interactionoptical measurementphospholipids

Identifiers

PMID30463988
PMCPMC6314248
OpenAlexW2900703586

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.